Pseudomyxoma peritonei differential diagnosis

Revision as of 20:13, 18 January 2019 by Nima Nasiri (talk | contribs)
Jump to navigation Jump to search

Pseudomyxoma peritonei Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Pseudomyxoma peritonei from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pseudomyxoma peritonei differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pseudomyxoma peritonei differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pseudomyxoma peritonei differential diagnosis

CDC on Pseudomyxoma peritonei differential diagnosis

Pseudomyxoma peritonei differential diagnosis in the news

Blogs on Pseudomyxoma peritonei differential diagnosis

Directions to Hospitals Treating Pseudomyxoma peritonei

Risk calculators and risk factors for Pseudomyxoma peritonei differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Nima Nasiri, M.D.[2]Parminder Dhingra, M.D. [3]

Overview

Pseudomyxoma peritonei must be differentiated from peritoneal carcinomatosis without mucinous ascites, peritoneal sarcomatosis, and peritonitis.

Differential Diagnosis

Pseudomyxoma peritonei must be differentiated from:[1][2]

  • Peritoneal carcinomatosis without mucinous ascites
  • Peritoneal sarcomatosis
  • Peritonitis

Differentiating pseudomyxoma peritonei from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]

  • On the basis bloating, abdominal distention, infertility and hernia , must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].
Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Signs
Lab Findings Imaging Histopathology
Symptom Constitutional symptoms Physical exam CBC Immunohistochemistry CT Scan MRI Ultrasound
Pseudomyxoma peritonei[3][4]
  • Bloating
  • Abdominal distention
  • Negative
  • Abdominal tenderness
  • Non specific
  • CK 20, CDX2 and MUC2,MUC5AC
  • Low-attenuation
  • Scalloping of the visceral surfaces differentiates pseudomyxoma from other causes of peritnoitis.
  • Typically does not invade visceral organs or spread by lymphatic or hematogenous routes unlike mucinous carcinomatosis
  • The mucin has high signal intensity on T2-weighted MR images and low signal intensity on T1-weighted images
  • The echoes within pseudomyxoma peritonei are not mobile
  • Echogenic septations within the gelatinous ascites are frequently observed.
  • Scalloping of the hepatic and splenic margins
  • Gelatinous ascites in peritoneum and visceral organs,usually right hemidiaphragm, liver.
  • Diagnostic laparascopy/laparatomy
Peritoneal carcinomatosis without mucinous ascites
  • Abdominal pain
  • Abdominal distention
  • Negative
  • Abdominal distention
  • Abdominal pain
  • Non specific
  • Pleural effusion and/or masses in chest
  • Mesenteric or retroperitoneal lymphadenopathy
  • Omental caking, and invasion into parenchymal organs
  • Echoes are mobile
  • No scallioping of visceral organs.
Peritoneal sarcomatosis
  • Abdominal pain
  • Abdominal distention
  • Bloating
  • Nausea
  • Negative
  • Abdominal mass
  • Non specific
  • Heterogeneous bulky masses
  • Hypervascularity with or without
  • Hemoperitoneum Variable presence of ascites.
  • CT-guided percutaneous tissue biopsy
Lymphomatosis
  • Abdominal pain
  • Blaoting
  • Swollen lymph node
  • Fever
  • Night sweat
  • Weight loss
  • Splenomegaly
  • Lymphadenopathy
  • Abdominal mass
  • Abdominal tenderness
  • Anemia
  • Pancytopenia
  • Thrombocytopenia
  • Thrombocytosis
  • CD20,
  • CD79a,
  • CD10
  • Mostly non-specific
  • Aneurysmal dilatation of the bowel loop with wall thickening may differentiate lymphomatosis from other peritoneal diseases.
  • Atypical lymphoid cells
  • Biopsy and histology
  • Rare manifestation of lymphoma, seen most frequently with non-Hodgkin lymphoma
  • Associated with Herpes virus 8 (HHV-8), which is also associated with Kaposi sarcoma, and Epstein-Barr virus
Tuberclousis Peritonitis[5][5]
  • Abdominal pain
  • Fever
  • Night sweat
  • Weight loss
  • A positive tuberculin skin test
  • Ascitic fluid will have an elevated white blood cell count with a lymphocytic predominance
  • Elevated serum CA 125 level
  • Normal serum CA 19-9, and CEA associated with lymphocyte predominant benign ascites
  • Miliary microabscesses in the liver or spleen
  • lymph node calcification
  • Inflammatory thickening of the terminal ileum and cecum
  • low-attenuation lymphadenopathy
  • Caseating granuloma with central area of necrotic acellular debris surrounded by histiocytes
  • Laparoscopy and peritoneal biopsy
  • Tuberclousis
Endometriosis[6][7][8]
  • Menstrual cramps
  • Painful bowel movements
  • Painful urination during menstrual periods
  • Heavy menstrual periods
  • Pain during or after sex
  • Negative
  • Immobile uterine
  • Cervical motion tenderness
  • Fixed and retroverted uterus
  • Tender adnexal mass
  • Tender uterosacral nodularity
  • Thomsen-Friedenreich (T) antigen (Gal beta1-3GalNAc)
  • Endometrial-type glands and stroma, as well as hemosiderin-laden macrophages
  • Hemorrhagic, reddish brown or blue nodules or cysts on the peritoneal surfaces
  • Visual inspection with laparascopy
Sclerosing encapsulating peritonitis[9]
  • Fever,
  • Weight loss,
  • Loss of appetite
  • Altered bowel movement
  • Episodes of intermittent, partial small bowel obstruction
  • Diffusely thickened peritoneum and ascites
  • Small bowel may be matted within loculated fluid collections
  • Dense,opaque peritoneum
  • Progressive collagen formation with an associated chronic inflammatory infiltrate
Gliomatosis Peritonei[10][11]
  • Abdominal pain
  • Bloating
  • Negative
  • SOX2+/OCT4-/NANOG- immunophenotype
  • Mature glial tissue in the peritoneal cavity
  • Micronodular growth pattern
  • Association with solid or immature ovarian teratomas, but it has also been reported to occur in association with ventriculoperitoneal shunts
Osseous metaplasia
  • Abdominal pain
  • Nausea
  • Vomiting
  • Bloating
  • Negative
  • Multiple, high-attenuation, linear-branching structures within the mesentery that extend to the peritoneal surfaces
Splenosis
  • Abdominal mass
  • Negative
  • Lesions are typically multiple, small, reddish-brown nodules that range in size from a few millimeters to 7 cm
Melanosis
  • Negative
  • Pigmentation within the dermoid, omentum, and peritoneal cavity
  • Pigment-laden macrophages within the mucosa on PAS staining
  • Biopsy and histology
  • Enteric duplication cyst
  • Associated with ovarian cystic teratomas
Inflammatory Pseudotumor
  • Fever
  • Weight loss
  • Anemia
  • Negative
  • Anemia
  • Thrombocytosis
  • Polyclonal hypergammaglobulinemia
  • Stain positive for ALK with immunohistochemistry
  • Loose myxoid areas with interspersed spindle cells,
  • Variable vascularity
  • Areas of dense collagen, and dense spindled myofibroblasts admixed with inflammatory cells to include plasma cells and lymphocytes.
  • Chromosomal translocations involving the ALK gene

References

  1. Harmon RL, Sugarbaker PH (February 2005). "Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer". Int Semin Surg Oncol. 2 (1): 3. doi:10.1186/1477-7800-2-3. PMC 549516. PMID 15701175.
  2. Carr NJ, Bibeau F, Bradley RF, Dartigues P, Feakins RM, Geisinger KR, Gui X, Isaac S, Milione M, Misdraji J, Pai RK, Rodriguez-Justo M, Sobin LH, van Velthuysen MF, Yantiss RK (December 2017). "The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei". Histopathology. 71 (6): 847–858. doi:10.1111/his.13324. PMID 28746986.
  3. Carranza-Martínez I, Cornejo-López G, Monroy-Argumedo M, Villanueva-Sáenz E (2014). "[Pseudomyxoma peritonei. Two-case-report]". Cir Cir (in Spanish; Castilian). 82 (2): 206–11. PMID 25312322.
  4. Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (December 1995). "Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei"". Am. J. Surg. Pathol. 19 (12): 1390–408. PMID 7503361.
  5. 5.0 5.1 Kaya M, Kaplan MA, Isikdogan A, Celik Y (2011). "Differentiation of tuberculous peritonitis from peritonitis carcinomatosa without surgical intervention". Saudi J Gastroenterol. 17 (5): 312–7. doi:10.4103/1319-3767.84484. PMC 3178918. PMID 21912057.
  6. DiVasta AD, Vitonis AF, Laufer MR, Missmer SA (March 2018). "Spectrum of symptoms in women diagnosed with endometriosis during adolescence vs adulthood". Am. J. Obstet. Gynecol. 218 (3): 324.e1–324.e11. doi:10.1016/j.ajog.2017.12.007. PMID 29247637.
  7. Yeaman GR, Collins JE, Lang GA (March 2002). "Autoantibody responses to carbohydrate epitopes in endometriosis". Ann. N. Y. Acad. Sci. 955: 174–82, discussion 199–200, 396–406. PMID 11949946.
  8. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, Hummelshoj L, Prentice A, Saridogan E (October 2005). "ESHRE guideline for the diagnosis and treatment of endometriosis". Hum. Reprod. 20 (10): 2698–704. doi:10.1093/humrep/dei135. PMID 15980014.
  9. Suh WN, Lee SK, Chang H, Hwang HJ, Hyung WJ, Park YN, Kim TI (June 2007). "Sclerosing encapsulating peritonitis (abdominal cocoon) after abdominal hysterectomy". Korean J. Intern. Med. 22 (2): 125–9. PMC 2687622. PMID 17616031.
  10. Liang L, Zhang Y, Malpica A, Ramalingam P, Euscher ED, Fuller GN, Liu J (December 2015). "Gliomatosis peritonei: a clinicopathologic and immunohistochemical study of 21 cases". Mod. Pathol. 28 (12): 1613–20. doi:10.1038/modpathol.2015.116. PMC 4682736. PMID 26564007.
  11. Lovell MA, Ross GW, Cooper PH (April 1989). "Gliomatosis peritonei associated with a ventriculoperitoneal shunt". Am. J. Clin. Pathol. 91 (4): 485–7. PMID 2648802.

Template:WH Template:WS

References


Template:WikiDoc Sources